Disease-modifying therapies for multiple sclerosis

What you need to know: Disease-modifying therapies (DMTs) early in the course of active relapsing multiple sclerosis can prevent relapses, new brain and spinal cord lesions, and worsening neurological disability; Some DMTs are associated with potentially serious adverse reactions, and careful monito...

Full description

Saved in:

Bibliographic Details
Published in:	BMJ (Online) Vol. 363; p. k4674
Main Authors:	De Angelis, Floriana, John, Nevin A, Brownlee, Wallace J
Format:	Journal Article
Language:	English
Published:	England BMJ Publishing Group LTD 27.11.2018
Subjects:	Blood pressure Case reports Clinical decision making Clinical trials Copolymer 1 Cost analysis Creatinine Decision making Drug dosages Drug therapy Echocardiography EKG Evidence-based medicine Hepatitis B HIV Human immunodeficiency virus Injection Interferon Leukoencephalopathy Magnetic resonance imaging Monoclonal antibodies Multiple sclerosis Neurology Patient care planning Progressive multifocal leukoencephalopathy Thrombocytopenic purpura Thyroid Tuberculosis Urea Varicella United Kingdom > UK
ISSN:	0959-8138, 1756-1833, 1756-1833
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!